473838-36-7 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
1-Benzyl-3,3-diMethyl-piperidin-4-aMine serves as an intermediate in the synthesis of pharmaceuticals and agrochemicals, contributing to the development of new drugs and pesticides. Its unique chemical properties facilitate the creation of diverse therapeutic agents and agricultural products.
Used in Organic Compound Production:
As a building block, 1-Benzyl-3,3-diMethyl-piperidin-4-aMine is utilized in the production of other organic compounds such as dyes and surfactants. Its structural features allow for the synthesis of a wide range of chemical products with various applications in different industries.
Used in Neurological Disorder Treatment Research:
1-Benzyl-3,3-diMethyl-piperidin-4-aMine has been studied for its potential use in the treatment of neurological disorders. Its chemical properties may offer new avenues for therapeutic intervention in conditions affecting the nervous system.
Used in Antidepressant Development:
1-Benzyl-3,3-diMethyl-piperidin-4-aMine is also being investigated for its potential as an antidepressant. Its unique structure and properties could lead to the development of novel treatments for mood disorders, providing new options for patients and healthcare providers.
Check Digit Verification of cas no
The CAS Registry Mumber 473838-36-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,3,8,3 and 8 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 473838-36:
(8*4)+(7*7)+(6*3)+(5*8)+(4*3)+(3*8)+(2*3)+(1*6)=187
187 % 10 = 7
So 473838-36-7 is a valid CAS Registry Number.
473838-36-7Relevant academic research and scientific papers
SULFONYLATED TETRAHYDROAZOLOPYRAZINES AND THEIR USE AS MEDICINAL PRODUCTS
-
Page/Page column 105, (2010/09/18)
The present invention relates to sulfonylated tetrahydroazolopyrazines, methods for the preparation thereof, medicinal products containing these compounds and the use of substituted indole compounds for the preparation of medicinal products (Formula I).
CCR8 INHIBITORS
-
Page 26; 28, (2008/06/13)
Disclosed is an inhibitor of CCR8 that is represented by Structural Formula (I). Also disclosed are pharmaceutical compositions comprising a pharmaceutically acceptable carrier or diluent and a CCR8 inhibitor represented by Structural Formula (I). Also disclosed is a method of treating inflammatory disorders in a subject by administering a CCR8 inhibitor to the subject.
CCR8 INHIBITORS
-
Page 31-32, (2008/06/13)
Disclosed are CCR8 inhibitors represented by Structural Formulas (I). The variables in Structural Formula (I) are described herein. Also disclosed are methods of treating a subject with a CCR8 mediated condition, especially asthma, by administering one of the disclosed CCR8 inhibitors to the subject.
